References
- Abita J P., Delage M, Lazdunski M. The mechanism of activation of trypsiongen. Eur J Biochem 1969; 8: 314–24
- Geokas M C. Acute pancreatitis. Ann Intern Med 1985; 103: 86–100
- Ohlsson K, Balldin G, Bohe M, Borgström A, Genell S, Lasson Å. Pancreatic proteases and antiproteases in pancreatic disease; biochemical, pathophysiological and clinical aspects. Int. Symp. Pancr. Cancer: Biochemical and Clinical Aspects. Policlinico Universitario, Padova, Italien, 24–25 okt. 1986. Int J Pancreatology 1988; 3: 67–78
- Balldin G, Ohlsson K. Demonstration of pancreatic protease-antiprotease complexes in the peritoneal fluid of patients with acute pancreatitis. Surgery 1979; 85: 451–6
- Lasson Å, Ohlsson K. An in vitro study of the influence of plasma protease inhibitors and approtinin on trypsin-induced C3 cleavage in human serum. Biochim Biophys Acta 1982; 709: 227–33
- Ohlsson K, Eddeland A. Release of proteolytic enzymes in bile-induced pancreatitis in dogs. Gastroenterology 1975; 69: 668–75
- Renner I G., Rinderknecht H, Douglas A P. Profiles of pure pancreatic secretions in patients with acute pancreatitis. The possible role of proteolytic enzymes in pathogenesis. Gastroenterology 1978; 75: 1090–8
- Mallory P A., Travis J. Human pancreatic proteolytic enzymes: Purification and characterization of a nonelastolytic enzyme. Biochemistry 1975; 14: 722–30
- Ohlsson K, Olsson A S. Purification and partial characterization of human pancreatic elastase. Hoppe-Seyler's Z Physiol Chem 1976; 357: 1153–61
- Kimland M, Russick C, Marks W H., Borgström A. Immunoreactive anionic and cationic trypsin in human serum. Clin Chim Acta 1989; 184: 31–46
- Johansson B G. Agarose gel electrophoresis. Scand J Clin Lab Invest 1972; 29: 7–19, suppl. 124
- Laurell C B. Electroimmunoassay. Scand J Clin Lab Invest 1972; 29: 21–37, suppl. 124
- Ganrot P O. Crossed Immunoelectrophoresis. Scan J Clin Lab Invest 1972; 29: 39–47, suppi. 124
- Borgström A, Kukora J, Ohlsson K. Studies on immunoreactive pancreatic elastase 2 in human serum. Hoppe-Seyler's Z Physiol Chem 1980; 361: 633–40
- Borgström A, Ohlsson K. Radioimmunological determination and characterization of cathodal trypsin-like immunoreactivity in normal human plasma. Scand J Clin Lab Invest 1976; 36: 809–14
- Del Mar E G., Largman C, Brodrick J W., Fassett M, Geokas M C. Substrate specificity of human pancreatic elastase 2. Biochem 1980; 19: 468–72
- Erlanger B F., Kokowsky N, Cohen W. The preparation and properties of two new chromogenic substrates of trypsin. Arch Biochem Biophys 1961; 95: 271–8
- Starkey P M., Barrett A J. Neutral proteinases of human spleen, purification and criteria for homogeneity of elastase and cathepsin G. Biochem J 1976; 155: 255–63
- Ohlsson K, Olsson I. The neutral proteases of human granulocytes. Isolation and partial characterization of granulocyte elastases. Eur J Biochem 1974; 42: 519–27
- Lassen M. Heat denaturation of plasminogen in the fibrin plate method. Acta Physiol Scand 1952; 27: 371–6
- Kunitz M. Crystalline soybean trypsin inhibitor. J Gen Physiol 1947; 30: 291–310
- Blarney S L., Imrie C W., O'Neill J, Gilmour W H., Carter D C. Prognostic factors in acute pancreatitis. Gut 1984; 25: 1340–6
- Travis J, Johnson D. Human alphal proteinase inhibitor. Meth in Enzymology 1981; 80: 754–65
- Eriksson S. Determination of serum trypsin inhibitor capacity. Acta Med Scand 1965; 177: 6–12
- Håkansson H O., Ohlsson K. Interactions in vitro and in vivo between human and porcine cationic pancreatic elastase and plasma protease inhibitors. Biol Chem Hoppe-Seyler 1988; 369: 309–15
- Dubick M A., Geokas M C., Mayer A D., Majumbar A PN, Mar G, McMahon M J. Biochemical studies in peritoneal fluid from patients with acute pancreatitis. Dig Dis Sci 1987; 32: 305–12
- Largman C, Brodrick J W., Geokas M C., Sischo W M., Johnson J H. Formation of stable complex between human proelastase 2 and human alphal protease inhibitor. J Biol Chem 1979; 254: 8516–23
- Largman C, Brodrick J W., Geokas M C., Johnson J H., Fassett M. Demonstration of a pancreatic proelastase 2- alphal protease inhibitor complex in normal human plasma. Am J Physiol 1980; 238: G177–82
- Mayer A D., Airey M, Hodgson J, McMahon M J. Enzyme transfer from pancreas to plasma during acute pancreatitis. The contribution of ascitic fluid and lymphatic drainage of the pancreas. Gut 1985; 26: 876–81
- Ohlsson K, Laurell C B. The disappearance of enzyme-inhibitor complexes from the circulation of man. Clin Sci Mol Med 1976; 51: 87–92
- Borgström A. The fate of intravenously injected trypsinogens in dogs. Scand J Gastroenterol 1981; 16: 281–7